Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IW-6463 in healthy elderly participants
NL-OMON48314Completed
- Sponsor
- Cyclerion Therapeutics
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in mixed dementia, Alzheimer's disease (AD) and Dementia comparing IW-6463 with Placebo (2 arms). Primary endpoints: Change from baseline in cerebral blood flow and Treatment-emergent adverse events. Started Nov 2019; status: completed.
02
Drugs
zagociguat
03
Conditions
mixed dementiaAlzheimer's disease (AD)Dementia
Beyond the preview
Go deeper on NL-OMON48314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48314.